发明名称 | Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof | ||
摘要 | The present invention relates to novel pyrimidine hydroxy amide compounds, and the use of such compounds in the inhibition of HDAC6 and in the treatment of various diseases, disorders or conditions related to HDAC6. | ||
申请公布号 | US9409890(B2) | 申请公布日期 | 2016.08.09 |
申请号 | US201314082472 | 申请日期 | 2013.11.18 |
申请人 | ACETYLON PHARAMCEUTICALS, INC. | 发明人 | van Duzer John H.;Mazitschek Ralph;Ding Yanbing;Yu Nan;Cao Yun;Liu Yong |
分类号 | A61K31/505;A61K31/506;C07D239/42;C07D405/12;C07D401/12;C07D401/14;C07D403/12;C07D409/12 | 主分类号 | A61K31/505 |
代理机构 | Lathrop & Gage LLP | 代理人 | Lathrop & Gage LLP ;Trinque Brian C. |
主权项 | 1. A method of treating multiple myeloma in a subject comprising administering to the subject a compound of formula VI: or a pharmaceutically acceptable salt thereof,wherein, Rx and Ry together with the carbon to which each is attached, form a cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, tetrahydropyranyl, piperidinyl, piperazinyl, morpholinyl, tetrahydrofuranyl, tetrahydrothiophenyl, pyrrolidinyl, oxazolidinyl, or imidazolidinyl; each RA is independently alkyl, alkoxy, cycloalkyl, aryl, heterocycloalkyl, heteroaryl, arylalkyl, heteroarylalkyl, haloalkyl, haloalkoxy, halo, OH, —NO2, —CN, or —NH2; and m is 0, 1, or 2. | ||
地址 | Boston MA US |